Rubicon Research IPO listing date has been scheduled for today (Thursday, October 16) on the bourses at 10:00 IST. Rubicon Research IPO allotment was finalised on Tuesday, October 14. According to ...

The homesteading pros at Gold Shaw Farm share what a Mario-inspired plumbing hack can teach you. Trump Cuts Millions After California Ignores English Rule 1 dead, 6 injured in shooting during ...

Pharmaceutical company Rubicon Research's initial public offering witnessed 48 times subscription so far on the third day of bidding on October 13. The company's IPO got bids for 179,32,68,430 shares ...

Pharmaceutical company Rubicon Research's initial public offering got fully subscribed on the second day of bidding on October 10. The company's IPO got bids for 1,91,32,230 shares against 1,64,55,670 ...

Rubicon Research IPO Allotment Status: Investors who have applied for the Rubicon Research IPO can check their allotment status online on the websites of BSE, NSE, or the issue registrar-MUFG Intime ...

Sarah Annesley receives funding from ME Research UK, The Judith Jane Mason & Harold Stannett Williams Memorial Foundation and the Medical Research Future Fund (MRFF035120). Scientists in the United ...

An aerial view of the UC San Diego campus. (FIle photo courtesy of UCSD) Key discoveries in the human immune system have led UC San Diego alum Fred Ramsdell to receive a Nobel Prize in Physiology or ...

Tara Djokic and co-authors received funding for this research from the Etheridge family descendants; Australian Museum Research Institute, Australian Museum Trust; and Australian Research Council (ARC ...

Fair attendees in front of an AI sign at the World Artificial Intelligence Conference in Shanghai on July 27, 2025. (Ying Tang/NurPhoto via Getty Images) How we did this This Pew Research Center ...

National security, unlocked. Each Thursday, host Mary Louise Kelly and a team of NPR correspondents discuss the biggest national security news of the week. With decades of reporting from battlefields ...

While developing mRNA vaccines for patients with brain tumors in 2016, our team, led by pediatric oncologist Elias Sayour, discovered that mRNA can train immune systems to kill tumors — even if the ...